Latest Eversept Partners, LP Stock Portfolio
Eversept Partners, LP Performance:
2025 Q3: 11.98%YTD: 2.02%2024: 19.98%
Performance for 2025 Q3 is 11.98%, and YTD is 2.02%, and 2024 is 19.98%.
About Eversept Partners, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Eversept Partners, LP reported an equity portfolio of $1.5 Billions as of 30 Sep, 2025.
The top stock holdings of Eversept Partners, LP are UTHR, , NTRA. The fund has invested 7.3% of it's portfolio in UNITED THERAPEUTICS CORP DEL and 6.3% of portfolio in GSK PLC.
The fund managers got completely rid off INSPIRE MED SYS INC (INSP), IQVIA HLDGS INC (IQV) and PROTAGONIST THERAPEUTICS INC (PTGX) stocks. They significantly reduced their stock positions in MIRUM PHARMACEUTICALS INC (MIRM), HEALTHEQUITY INC (HQY) and MERUS N V (MRUS). Eversept Partners, LP opened new stock positions in UNIQURE NV (QURE), ABIVAX SA and INSULET CORP (PODD). The fund showed a lot of confidence in some stocks as they added substantially to REPLIGEN CORP (RGEN), UNITED THERAPEUTICS CORP DEL (UTHR) and DANAHER CORPORATION (DHR).
The top stock holdings of Eversept Partners, LP are UTHR, , NTRA. The fund has invested 7.3% of it's portfolio in UNITED THERAPEUTICS CORP DEL and 6.3% of portfolio in GSK PLC.
The fund managers got completely rid off INSPIRE MED SYS INC (INSP), IQVIA HLDGS INC (IQV) and PROTAGONIST THERAPEUTICS INC (PTGX) stocks. They significantly reduced their stock positions in MIRUM PHARMACEUTICALS INC (MIRM), HEALTHEQUITY INC (HQY) and MERUS N V (MRUS). Eversept Partners, LP opened new stock positions in UNIQURE NV (QURE), ABIVAX SA and INSULET CORP (PODD). The fund showed a lot of confidence in some stocks as they added substantially to REPLIGEN CORP (RGEN), UNITED THERAPEUTICS CORP DEL (UTHR) and DANAHER CORPORATION (DHR).
Eversept Partners, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Eversept Partners, LP made a return of 11.98% in the last quarter. In trailing 12 months, it's portfolio return was -4.39%.
New Buys
| Ticker | $ Bought |
|---|---|
| uniqure nv | 51,212,300 |
| abivax sa | 36,209,800 |
| insulet corp | 14,079,300 |
| avidity biosciences inc | 13,197,800 |
| novo-nordisk a s | 12,080,600 |
| ars pharmaceuticals inc | 9,813,940 |
| biomarin pharmaceutical inc | 7,942,130 |
| ardelyx inc | 7,875,870 |
New stocks bought by Eversept Partners, LP
Additions
| Ticker | % Inc. |
|---|---|
| repligen corp | 464 |
| united therapeutics corp del | 326 |
| danaher corporation | 323 |
| mannkind corp | 192 |
| elevance health inc formerly | 137 |
| geron corp | 72.11 |
| structure therapeutics inc | 67.5 |
| 89bio inc | 66.3 |
Additions to existing portfolio by Eversept Partners, LP
Reductions
| Ticker | % Reduced |
|---|---|
| mirum pharmaceuticals inc | -78.76 |
| healthequity inc | -66.39 |
| merus n v | -63.3 |
| humana inc | -61.82 |
| nektar therapeutics | -56.62 |
| maravai lifesciences hldgs i | -54.63 |
| molina healthcare inc | -54.03 |
| zenas biopharma inc | -51.23 |
Eversept Partners, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| autolus therapeutics plc | -1,391,330 |
| protagonist therapeutics inc | -15,327,300 |
| karyopharm therapeutics inc | -1,108,330 |
| puma biotechnology inc | -825,560 |
| globus med inc | -10,012,300 |
| inspire med sys inc | -21,343,700 |
| iteos therapeutics inc | -1,089,960 |
| ac immune sa | -204,527 |
Eversept Partners, LP got rid off the above stocks
Sector Distribution
Eversept Partners, LP has about 82.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 82.3 |
| Others | 15.8 |
Market Cap. Distribution
Eversept Partners, LP has about 33.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 31.8 |
| SMALL-CAP | 27.4 |
| MID-CAP | 21.3 |
| UNALLOCATED | 16.9 |
| MEGA-CAP | 1.7 |
Stocks belong to which Index?
About 53.2% of the stocks held by Eversept Partners, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 46.8 |
| RUSSELL 2000 | 37.9 |
| S&P 500 | 15.3 |
Eversept Partners, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Eversept Partners, LP
Eversept Partners, LP has 83 stocks in it's portfolio. About 44.6% of the portfolio is in top 10 stocks. BRKR proved to be the most loss making stock for the portfolio. SNDX was the most profitable stock for Eversept Partners, LP last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACAD | acadia pharmaceuticals inc | 0.24 | 164,237 | 3,504,820 | new | |||
| ADGI | invivyd inc | 0.16 | 2,047,260 | 2,251,990 | new | |||
| ALEC | alector inc | 0.30 | 1,488,720 | 4,406,630 | reduced | -25.04 | ||
| AMRN | amarin corp plc | 0.19 | 167,276 | 2,739,980 | unchanged | 0.00 | ||
| ARCT | arcturus therapeutics hldgs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARDX | ardelyx inc | 0.54 | 1,429,380 | 7,875,870 | new | |||
| ARQT | arcutis biotherapeutics inc | 0.14 | 111,466 | 2,101,130 | new | |||
| AUTL | autolus therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVTR | avantor inc | 0.80 | 924,442 | 11,537,000 | reduced | -39.43 | ||
| BCRX | biocryst pharmaceuticals inc | 0.72 | 1,373,620 | 10,425,800 | added | 13.74 | ||
| BCYC | bicycle therapeutics plc | 0.10 | 194,440 | 1,504,970 | reduced | -8.05 | ||
| BIIB | biogen inc | 0.50 | 51,765 | 7,251,240 | new | |||
| BMRN | biomarin pharmaceutical inc | 0.55 | 146,642 | 7,942,130 | new | |||
| BRKR | bruker corp | 1.54 | 687,129 | 22,324,800 | reduced | -18.13 | ||
| BVS | bioventus inc | 0.20 | 433,933 | 2,903,010 | new | |||
| CLDX | celldex therapeutics inc new | 2.06 | 1,153,920 | 29,851,900 | added | 37.58 | ||
| CNC | centene corp del | 0.55 | 224,550 | 8,011,940 | reduced | -43.68 | ||
| CPRX | catalyst pharmaceuticals inc | 0.48 | 350,812 | 6,911,000 | new | |||
| CYH | community health sys inc new | 1.54 | 6,950,050 | 22,309,700 | added | 13.11 | ||
| DHR | danaher corporation | 1.36 | 99,273 | 19,681,900 | added | 323 | ||